Literature DB >> 18723135

Assembly of the RFX complex on the MHCII promoter: role of RFXAP and RFXB in relieving autoinhibition of RFX5.

Colin W Garvie1, Jeremy M Boss.   

Abstract

The RFX complex is key component of a multi-protein complex that regulates the expression of the Major Histocompatibility Class II (MHCII) genes, whose products are essential for the initiation and development of the adaptive immune response. The RFX complex is comprised of three proteins--RFX5, RFXAP, and RFXB--all of which are required for expression of MHCII genes. We have used electrophoretic mobility shift assays to characterize the DNA binding of RFX5 and the complexes it forms with RFXB and RFXAP, to the proximal regulatory region of the MHCII promoter. DNA binding of RFX5 is inhibited by domains flanking its DNA binding domain, and both RFXAP and RFXB are required to overcome the inhibition of both domains. We provide evidence that a single RFX complex binds to the proximal regulatory region of the MHCII promoter and identify regions of the DNA that are important for high affinity binding of the RFX complex. Together, our results provide the most detailed view to date of the assembly of the RFX complex on the MHCII promoter and how its DNA binding is regulated.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723135     DOI: 10.1016/j.bbagrm.2008.07.012

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  10 in total

Review 1.  Regulation of major histocompatibility complex class II genes.

Authors:  Nancy M Choi; Parimal Majumder; Jeremy M Boss
Journal:  Curr Opin Immunol       Date:  2010-10-21       Impact factor: 7.486

2.  Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.

Authors:  Suhani Thakker; Pravinkumar Purushothaman; Namrata Gupta; Shanthan Challa; Qiliang Cai; Subhash C Verma
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

3.  IFN-γ induces the upregulation of RFXAP via inhibition of miR-212-3p in pancreatic cancer cells: A novel mechanism for IFN-γ response.

Authors:  Guoping Ding; Liangjing Zhou; Tao Shen; Liping Cao
Journal:  Oncol Lett       Date:  2018-01-12       Impact factor: 2.967

4.  Solution structure of the heterotrimeric complex between the interaction domains of RFX5 and RFXAP from the RFX gene regulatory complex.

Authors:  Kholiswa M Laird; LaTese L Briggs; Jeremy M Boss; Michael F Summers; Colin W Garvie
Journal:  J Mol Biol       Date:  2010-08-21       Impact factor: 5.469

5.  HLA-DRB1 genes and the expression dynamics of HLA CIITA determine the susceptibility to T2DM.

Authors:  Rathika Chinniah; Vandit Sevak; Sasiharan Pandi; Padma Malini Ravi; Murali Vijayan; Arun Kannan; Balakrishnan Karuppiah
Journal:  Immunogenetics       Date:  2021-03-22       Impact factor: 2.846

Review 6.  Structural aspects of the MHC expression control system.

Authors:  Grady Nash; Bhaskar Paidimuddala; Liman Zhang
Journal:  Biophys Chem       Date:  2022-02-15       Impact factor: 2.352

7.  On characterizing adaptive events unique to modern humans.

Authors:  Jessica L Crisci; Alex Wong; Jeffrey M Good; Jeffrey D Jensen
Journal:  Genome Biol Evol       Date:  2011-07-29       Impact factor: 3.416

8.  Comprehensive Review of Steroid-Sensitive Nephrotic Syndrome Genetic Risk Loci and Transcriptional Regulation as a Possible Mechanistic Link to Disease Risk.

Authors:  Hillarey K Stone; Sreeja Parameswaran; Amy A Eapen; Xiaoting Chen; John B Harley; Prasad Devarajan; Matthew T Weirauch; Leah Kottyan
Journal:  Kidney Int Rep       Date:  2020-10-16

9.  Integrative transcriptome-wide analysis of atopic dermatitis for drug repositioning.

Authors:  Jaeseung Song; Daeun Kim; Sora Lee; Junghyun Jung; Jong Wha J Joo; Wonhee Jang
Journal:  Commun Biol       Date:  2022-06-22

10.  Pancreatic cancer-derived exosomes transfer miRNAs to dendritic cells and inhibit RFXAP expression via miR-212-3p.

Authors:  Guoping Ding; Liangjing Zhou; Yingming Qian; Mingnian Fu; Jian Chen; Jionghuang Chen; Jianyang Xiang; Zhengrong Wu; Guixing Jiang; Liping Cao
Journal:  Oncotarget       Date:  2015-10-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.